Evidence map›Paper›PMID 21995287›Full record

ArticleBMC infectious diseases2011

A large sustained endemic outbreak of multiresistant Pseudomonas aeruginosa: a new epidemiological scenario for nosocomial acquisition.

Cristina Suarez, Carmen Peña, Olga Arch, M Angeles Dominguez, Fe Tubau, Carlos Juan, Laura Gavaldá, Mercedes Sora, Antonio Oliver, Miquel Pujol and 1 more

Open access · goldAbstract read
In one paragraph

Article in BMC infectious diseases, 2011. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 29 papers, 2 of them syntheses that pooled it.

0numbers the graph read from it
0cells of the map it votes in
29citing papers in PubMed, 2 pooled it
2.2field-weighted citation impact, top 13% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

29 citing papers in PubMed, 2 syntheses or guidelines pooled it, 63 citations in OpenAlex.

  1. Pooled it
  2. Pooled it
  3. TheJournal of bacteriology · 2026
    Article
  4. Review
  5. Article
  6. Article
  7. Article
  8. Antimicrobial resistance and genotyping ofFrontiers in veterinary science · 2023
    Article
  9. Non-fermenter Gram-negative bacilli at a tertiary hospital, South Africa.Southern African journal of infectious diseases · 2023
    Article
  10. The Effectiveness of Ultraviolet-C (UV-C) Irradiation on the Viability of AirborneInternational journal of environmental research and public health · 2022
    Article
  11. Article
  12. Article
  13. The Versatile Mutational Resistome ofFrontiers in microbiology · 2018
    Review
  14. Article
  15. Infections in intensive care unit adult patients harboring multidrug-resistant Pseudomonas aeruginosa: implications for prevention and therapy.European journal of clinical microbiology & infectious diseases : official publication of the European Society of Clinical Microbiology · 2017
    Observational
  16. Review
  17. Prolonged outbreak of clonal MDRAntimicrobial resistance and infection control · 2016
    Article
  18. Observational
  19. Review
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

11 authors at 4 institutions in 1 country.

Cristina SuarezIDIBELL, Infectious Diseases Service, Hospital Universitari de Bellvitge, University of Barcelona, Barcelona, Spain.
Carmen Peña
Olga Arch
M Angeles Dominguez
Fe Tubau
Carlos Juan
Laura Gavaldá
Mercedes Sora
Antonio Oliver
Miquel Pujol
Javier Ariza
Universitat de Barcelona · ESBellvitge University Hospital · ESHospital Universitario Son Espases · ESInstitut d'Investigació Biomédica de Bellvitge · ES

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

backgroundStudies of recent hospital outbreaks caused by multiresistant P.aeruginosa (MRPA) have often failed to identify a specific environmental reservoir. We describe an outbreak due to a single clone of multiresistant (MR) Pseudomonas aeruginosa (PA) and evaluate the effectiveness of the surveillance procedures and control measures applied.

methodsPatients with MRPA isolates were prospectively identified (January 2006-May 2008). A combined surveillance procedure (environmental survey, and active surveillance program in intensive care units [ICUs]) and an infection control strategy (closure of ICU and urology wards for decontamination, strict compliance with cross-transmission prevention protocols, and a program restricting the use of carbapenems in the ICUs) was designed and implemented.

resultsThree hundred and ninety patients were identified. ICU patients were the most numerous group (22%) followed by urology patients (18%). Environmental surveillance found that 3/19 (16%) non-ICU environmental samples and 4/63 (6%) ICU samples were positive for the MRPA clonal strain. In addition, active surveillance found that 19% of patients were fecal carriers of MRPA. Significant changes in the trends of incidence rates were noted after intervention 1 (reinforcement of cleaning procedures): -1.16 cases/1,000 patient-days (95%CI -1.86 to -0.46; p = 0.003) and intervention 2 (extensive decontamination): -1.36 cases/1,000 patient-days (95%CI -1.88 to -0.84; p < 0.001) in urology wards. In addition, restricted use of carbapenems was initiated in ICUs (January 2007), and their administration decreased from 190-170 DDD/1,000 patient-days (October-December 2006) to 40-60 DDD/1,000 patient-days (January-April 2007), with a reduction from 3.1 cases/1,000 patient-days in December 2006 to 2.0 cases/1,000 patient-days in May 2007. The level of initial carbapenem use rose again during 2008, and the incidence of MRPA increased progressively once more.

conclusionsIn the setting of sustained MRPA outbreaks, epidemiological findings suggest that patients may be a reservoir for further environmental contamination and cross-transmission. Although our control program was not successful in ending the outbreak, we think that our experience provides useful guidance for future approaches to this problem.

Indexed as

Disease OutbreaksDrug Resistance, Multiple, BacterialAdultAgedAged, 80 and overAnti-Bacterial AgentsCarbapenemsCarrier StateCluster AnalysisCross InfectionEndemic DiseasesFemaleGenotypeHumansIncidenceInfection ControlAnti-Bacterial AgentsCarbapenems

Identifiers

PMID21995287
PMCPMC3203071
OpenAlexW2002375372

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.